Canopy Growth (CGC) Capital Expenditures Growth (1y) (2020 - 2025)
Canopy Growth (CGC) Capital Expenditures Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | -21.54% |
| 10 | Canopy Growth | 275.57 Mn | 9.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 257.24% |
| Jun 30, 2025 | -67.11% |
| Dec 31, 2024 | 109.95% |
| Sep 30, 2024 | 268.74% |
| Jun 30, 2024 | 97.84% |
| Mar 31, 2024 | -91.50% |
| Dec 31, 2023 | -69.90% |
| Sep 30, 2023 | -66.69% |
| Jun 30, 2023 | -19.45% |
| Mar 31, 2023 | 4,201.17% |
| Dec 31, 2022 | 80.32% |
| Sep 30, 2022 | -87.35% |
| Jun 30, 2022 | -89.10% |
| Mar 31, 2022 | -99.95% |
| Dec 31, 2021 | 101.78% |
| Sep 30, 2021 | -43.17% |
| Jun 30, 2021 | -62.83% |
| Mar 31, 2021 | -79.04% |
| Dec 31, 2020 | 30.72% |
| Sep 30, 2020 | 607.09% |